Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages by Social Determinants of Health

被引:5
|
作者
Zhu, Ruixin [1 ]
Wang, Ran [1 ]
He, Jingjing [1 ]
Wang, Langrun [1 ]
Chen, Huiyu [1 ]
Niu, Xiaokang [1 ]
Sun, You [2 ]
Guan, Yiran [1 ]
Gong, Yifan [1 ]
Zhang, Liwei [1 ]
An, Peng [1 ]
Li, Keji [3 ]
Ren, Fazheng [1 ]
Xu, Weili [4 ]
Guo, Jie [1 ,4 ]
机构
[1] China Agr Univ, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual, 10 Tianxiu Rd, Beijing, Peoples R China
[2] Tianjin Univ Sci & Technol, Coll Food Sci & Engn, Tianjin, Peoples R China
[3] Peking Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing, Peoples R China
[4] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Solna, Sweden
基金
中国博士后科学基金;
关键词
US ADULTS; NHANES;
D O I
10.1001/jamanetworkopen.2024.45309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Cardiovascular-kidney-metabolic (CKM) syndrome-a novel, multistage, multisystem disorder as defined by the American Heart Association-is highly prevalent in the US. However, the prevalence of CKM stages by social determinants of health (SDOH) remains unclear. Objective To investigate whether the prevalence of CKM stages varies by SDOH in US adults. Design, Setting, and Participants This cross-sectional study used data from the National Health and Nutrition Examination Survey (1999-2018) and included a nationally representative sample of adults aged 30 to 79 years through complex, multistage probability sampling. Data were analyzed from April 1 to June 15, 2024. Exposures The exposures included 5 CKM stages (ie, stages 0-4) reflecting progressive pathophysiology, with advanced (stages 3 or 4) and nonadvanced (stages 0, 1, or 2) disease. CKM stages were defined based on risk factors for metabolic syndrome, cardiovascular disease, and chronic kidney disease. Main Outcome and Measures The main outcome was the age-standardized prevalence of CKM stages and advanced CKM stages across SDOH, including education, marital status, family income, food security, health insurance, employment, home ownership, and health care access. Results Among 29 722 participants (weighted mean [SE] age, 50.8 [0.1] years; weighted 50.7% male), the age-standardized prevalence of CKM stages 0 to 4 was 13.6% (95% CI, 13.0%-14.3%), 29.9% (95% CI, 29.1%-30.7%), 43.7% (95% CI, 42.9%-44.5%), 4.7% (95% CI, 4.4%-5.0%), and 8.1% (95% CI, 7.6%-8.5%), respectively. Significant differences were observed in the prevalence of CKM stages across all unfavorable SDOH of interest compared with their favorable counterparts, with unemployment (18.8% [95% CI, 17.7%-20.1%] vs 11.4% [95% CI, 11.0%-11.9%]), low family income (16.1% [95% CI, 15.4%-16.8%] vs 10.1% [95% CI, 9.5%-10.7%]), and food insecurity (18.3% [95% CI, 17.1%-19.6%] vs 11.7% [95% CI, 11.2%-12.2%]) associated with an increased likelihood of advanced CKM stages. Participants with 2 or more unfavorable SDOH were more likely to have advanced CKM stages (age-standardized prevalence, 15.8% [95% CI, 15.2%-16.5%] vs 10.5% [95% CI, 9.9%-11.1%] with <2 unfavorable SDOH). Living in a rented home (15.9% [95% CI, 14.7%-17.0%] vs 9.3% [95% CI, 8.7%-9.9%] owning the home) or not living with a partner (13.2% [95% CI, 12.3%-14.3%] vs 9.2% [95% CI, 8.5%-9.8%] living with a partner) increased the likelihood of advanced CKM stages in female but not male participants. Conclusions and Relevance In this cross-sectional study, disparities in the prevalence of CKM stages by SDOH, particularly family income, food security, and employment, with notable sex differences, were observed in US adults. These findings highlight the need to address inequities in CKM syndrome through targeted interventions.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Refocusing cardio-renal problems: the cardiovascular-kidney-metabolic syndrome and the chronic cardiovascular-kidney disorder
    Zoccali, Carmine
    Zannad, Faiez
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (09) : 1378 - 1380
  • [42] Association of Social Risk Factors with Cardiovascular-Kidney-Metabolic Syndrome at Baseline in Youth with Hypertension Disorders: A SUPERHERO Analysis
    Onugha, Elizabeth
    Vincent, Carol
    Harry, Giya
    Murphy, Maggie
    South, Andrew
    HYPERTENSION, 2024, 81
  • [43] Sex differences in cardiovascular-kidney-metabolic health for degenerative valvular heart disease
    Yang, Cheng
    Li, Ziang
    Xu, Haiyan
    Qian, Jie
    Wu, Yong-Jian
    CIRCULATION, 2024, 150
  • [44] Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
    Cao, Yifei
    Wang, Wenfeng
    Xie, Shidong
    Xu, Yanfang
    Lin, Zishan
    BMC PUBLIC HEALTH, 2025, 25 (01)
  • [45] Cardiovascular-Kidney-Metabolic Syndrome Burden and Disparities in the 2011-2020 National Health and Nutrition Examination Survey
    Ogungbe, Oluwabunmi V.
    Aryee, Ebenezer K.
    Turkson-Ocran, Ruth-Alma
    Ndumele, Chiadi E.
    Commodore-Mensah, Yvonne
    CIRCULATION, 2024, 149
  • [46] High Prevalence of Cardiovascular-Kidney-Metabolic Syndrome and Lack of Sex Disparities in Youth Referred for Hypertension Disorders: A SUPERHERO Analysis
    South, Andrew
    Baker-Smith, Carissa
    Campbell, Jessica
    Harry, Giya
    Laisure, John
    Murphy, Margaret
    Onugha, Elizabeth
    Pudupakkam, Ashna
    Riar, Sandeep
    Siddiqui, Sahar
    Walsh, Michael
    Vincent, Carol
    CIRCULATION, 2024, 150
  • [47] The implications of polygenic versus phenotypic characterization of obesity for cardiovascular-kidney-metabolic health
    Dikilitas, Ozan
    Naderian, Mohammadreza
    Kosel, Matt
    Hamed, Marwan
    Schaid, Daniel
    Kullo, Iftikhar
    CIRCULATION, 2024, 150
  • [48] Increased prevalence of cardiovascular-kidney-metabolic syndrome during COVID-19: A propensity score-matched study
    Trimarco, Valentina
    Izzo, Raffaele
    Pacella, Daniela
    Manzi, Maria Virginia
    Trama, Ugo
    Lembo, Maria
    Piccinocchi, Roberto
    Gallo, Paola
    Esposito, Giovanni
    Morisco, Carmine
    Rozza, Francesco
    Mone, Pasquale
    Jankauskas, Stanislovas S.
    Piccinocchi, Gaetano
    Santulli, Gaetano
    Trimarco, Bruno
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 218
  • [49] Association between systemic immune-inflammation index and cardiovascular-kidney-metabolic syndrome
    Gao, Chenxuan
    Gao, Shizhen
    Zhao, Renpei
    Shen, Peimin
    Zhu, Xiaorui
    Yang, Yane
    Duan, Conghao
    Wang, Yansi
    Ni, Huan
    Zhou, Lanping
    Xiang, Yunfang
    Li, MeiJu
    Xu, Zhao
    Wang, Yibing
    Yang, Haijie
    Zhao, Chuanwei
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [50] Sex Differences in the Association Between Thyroid Hormone Sensitivity and Cardiovascular-Kidney-Metabolic Syndrome
    Jiang, Lanxuan
    Zhou, Liyuan
    Liu, Jia
    Wang, Ying
    Wang, Guang
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,